Consider concomitant medications for risk of drug–drug interactions

The pre-treatment assessment must also include an evaluation for potential drug–drug interactions between HCV DAAs and concomitant medications, including over-the-counter and recreational drugs. The University of Liverpool’s Hepatitis Drug Interactions website (www.hep-druginteractions. org) is a very useful resource and contains regularly updated information.

Tags: CCK

PrintEmail